P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE

• SMART L.,
• SEGBEFIA C.,
• LATHAM T.,
• STUBER S.,
• AMISSAH-ARTHUR K.,
• LANE A.,
• DEI-ADOMAKOH Y.,
• WARE R.

Affiliations

SMART L.

1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES

SEGBEFIA C.

4 University of Ghana Medical School Department of Child Health, Accra, GHANA

LATHAM T.

1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES

STUBER S.

1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES

AMISSAH-ARTHUR K.

6 University of Ghana Medical School Ophthalmology Unit Department of Surgery, Accra, GHANA

LANE A.

1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES

DEI-ADOMAKOH Y.

8 University of Ghana Medical School Department Haematology, Accra, GHANA

WARE R.

1 Cincinnati Children’s Hospital Medical Center Division of Hematology, Cincinnati, UNITED STATES